Harrison's Principles of Internal Medicine, Eight Edition, 1977, pp. 1754-1755.* |
P. Boyle, “Some Recent Developments in the Epidemiology of Colorectal Cancer,” Management of Colorectal Cancer, Mosby, 1998, pp. 19-34. |
Midgley R.S., et al., “Systemic Adjuvant Chemotherapy for Colorectal Cancer,” Managament of Colorectal Cancer, Mosby, 1998, pp. 126-127. |
T.H. Corbett et al., “Response of Transplantable Tumors of Mice to Anthracenedione Derivatives Alone and in Combination With Clinically Useful Agents,” Cancer Treatment Reports, vol. 66, No. 5, 1982, pp. 1187-1200. |
T.H. Corbett et al., “Evaluation of Single Agents and Combinations of Chemotherapeutic Agents in Mouse, Colon Carcinomas,” Cancer, vol. 40, No. 5, 1977, pp. 2660-2680. |
F.M. Schabel et al., “Testing Therapeutic Hypotheses In Mice and Man: Observations On the Therapeutic Activity Against Advanced Solid Tumors of Mice Treated With Anticancer Drugs That Have Demonstrated or Potential Clinical Utility For Treatment of Advanced Solid Tumors of Man,” Cancer Drug Development, Part B. Methods in Cancer Research, vol. 17, New York, Academic Press Inc., 1979, pp. 3-51. |
Emerson, D.L. et al., “In Vivo Antitumor Activity of To New Seven-substituted Water-soluble Camptothecin Analogues,” Cancer Research, vol. 55, 1995, pp. 605-609. |